Kevin Tran, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5329 Osgood Ave N, Oak Park Heights, MN 55082 Phone: 651-779-1400 |
Douglas G Weiher, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 13481 60th St N, Oak Park Heights, MN 55082 Phone: 651-430-9990 Fax: 651-430-3448 |
News Archive
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the presentation of data from a Phase 2 clinical trial at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO) showing encouraging overall survival (OS) results with ARQ 197 in combination with erlotinib among patients with advanced, refractory non-small cell lung cancer.
Data from the first phase III clinical trial of NovoCure's NovoTTF device for treatment of patients with recurrent glioblastoma (GBM) were presented today as a late breaking abstract during the Neuro-Oncology session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Study results show that NovoTTF, a novel, non-invasive, portable medical device, may be as or more effective than the best available chemotherapies for GBM, but without the toxicity usually associated with cytotoxic or targeted treatments.
Antipsychotic drugs are initiated in patients with Alzheimer's disease (AD) more frequently than in the general population – already 2–3 years before the Alzheimer's diagnosis, according to a new study from the University of Eastern Finland. Most commonly, antipsychotics were initiated during the six months following the Alzheimer's diagnosis; however, the incidence of new antipsychotic users was high also later on. The results were published in British Journal of Psychiatry.
US research shows that infantile hemangiomas, otherwise known as "strawberry" birthmarks, grow faster and earlier than previously believed.
› Verified 2 days ago